The LYNDIBULIN brand, founded in 2007 (United States), from 4 sister brands and 2214 competing brands. The LYNDIBULIN brand is owned by Ziopharm Oncology, a company listed in New York. LYNDIBULIN belongs to the Biotechnology business sector.
Buy Ziopharm Oncology share with
(0% commission and fractional shares)
Your capital is subject to risk. Other fees apply. For more information, visit etoro.com/trading/fees.
